Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: patient recorded as having no known allergies to drugs attending: chief complaint: dyspnea major surgical or invasive procedure: abdominal port placement history of present illness: 54 y/o woman with metastatic ovarian cancer complicated by ascites requiring frequent paracentesis who is admitted to the icu after presenting to the emergency department with dyspnea. . her ascites has been a problem of late, and has required 2 paracentesis last week alone. she was in fact scheduled to have ir place a peritoneal port on . she underwent her last recieved chemo on ; and was transfused 2u prbc for hct 26 that day. she last underwent paracentesis on . . she awoke on the day of admission (sunday ) feeling short of breath, and with abdominal distension, and noted that this was similar to how she feels prior to paracentesis. she has not had any acute abdominal pain, but notes a bloating and a tightness sensation. she vomited once last night after eating and has had poor po intake at baseline. she also reports feeling increasingly weak. she has had no chest pain. . in the ed, she was afebrile 99.5, with bp 110/60, hr 120, 18, o2 sat 98% on ra. she was found to have a hct of 16 (down from 26 on ) and wbc of 1.0. a ct torso was performed in the ed which demonstrated no pe/dissection, but progression of omental/peritoneal disease with pockets of hyperdense ascites in luq and mid line lower abdomen which likley represent intraperitoneal hemmorhage mixed with ascites. surgery was consulted and felt that there was no need for surgical intervention. she was admitted to the for further monitoring. past medical history: 1. ovarian cancer diagnosed with stage i in with good surgical resection. ascites has been positive. received adjuvant with carboplatin and taxol with avastin received 6 cycles. had recurrent disease in and had gemcitabine, 7 cycles taxol, 4 cycles doxil, and started alimta on . 2. anxiety disorder followed by a psychiatrist 3. hypertension after treatment with avastin 4. dvt and bilateral subsegmental pe diagnosed social history: worked as a schoolteacher. does not smoke or drink. family history: she has one uncle who had prostate cancer. both her sister and brother have had basal cell carcinoma of the nose. there is no history of any breast, ovarian, uterine, or colorectal cancer. physical exam: vs 98.5 76 118/80 28 99%4l gen: nad heent: atnc, heent, eomi heart: rrr, no m/r/g lungs: ctab, no r/r/w abd: distended, soft, nt, nd extrem: no c/c/e neuro: nonfocal pertinent results: on admission: 10:35am glucose-126* urea n-26* creat-0.5 sodium-130* potassium-4.3 chloride-98 total co2-24 anion gap-12 10:35am alt(sgpt)-13 ast(sgot)-21 ck(cpk)-12* tot bili-0.2 10:35am ctropnt-<0.01 10:35am ck-mb-notdone 10:35am tot prot-4.0* calcium-7.1* phosphate-3.2 magnesium-1.9 10:35am wbc-1.0*# rbc-1.76*# hgb-5.5*# hct-16.0*# mcv-91 mch-30.9 mchc-34.1# rdw-18.6* 10:35am neuts-30* bands-0 lymphs-70* monos-0 eos-0 basos-0 atyps-0 metas-0 myelos-0 nuc rbcs-6* . imaging: ct of the chest without and with intravenous contrast : 1. no evidence of aortic dissection or pulmonary embolism. 2. interval disease progression involving the peritoneum and omentum within the abdomen and pelvis with increased ascites. pockets of ascites appear to display hyperdense components within it, noted within the left upper quadrant and lower midline abdomen which are suggestive of regions of intraperitoneal hemorrhage. no findings of active extravasation. 3. unchanged intrathoracic and abdomen/pelvic lymphadenopathy. 4. slightly prominent air- and fluid-filled loops of transverse colon without any secondary signs to suggest bowel obstruction. . ct abdomen : 1. no evidence of active extravasation. 2. stable appearance of known extensive metastatic disease with ascites, peritoneal and omental implants. stable appearance of high attenuation components in left upper quadrant within the ascites suggestive of regions of intraperitoneal hemorrhage. 3. interval development of small-to-moderate right pleural effusion. 4. dilated loops up to 7 cm of air and fecal material filled transverse and ascending colon, and cecum that is compatible with ileus. brief hospital course: and oncology course according to problem list. . # anemia: patient presented with a hematocrit of 16 in the setting of recent chemotherapy and no clear source of acute bleeding. an abdominal ct was performed and demonstrated ascitic fluid consistent with focal areas of hemorrahage from metastatic disease. this was thought to be the etiology of the patient's acute anemia and she was admitted to the for close monitoring. she was transfused a total of four units of blood and had a post-transfusion hct of 34, suggesting that her initial hct of 16 was erroneous. lovenox, which she takes because of a history of dvt/pe, was held. her hct remained stable and she was subsequently transferred to the medical floor for further management. on the floor patient had 1 l of fluid drained from abdominal port for comfort - the next day she had > 15 pt hct drop (30.4 -> 15.7). hemodynamics were stable. cta was performed which demonstrated no active source of bleeding from vessels. however, abdominal port was draining frank blood. patient was transfused 2 units, and hct increased to 28.6. again it was felt 15 hct was erroneous and perhaps due to dilution (port draw). regardless patient is suffering from intraperitoneal bleeding demonstrated by frank blood (drained from abdominal port). cta ruled out treatable vascular source, most likely bleeding is from metastatic peritoneal disease. there is some concern that removing fluid for comfort increases peritoneal bleeding due to decreased pressure/tamponade. however, prior to discharge 500 cc x 2 was drained with no significant drop in hct or change in hemodynamics. plan is to discontinue lovenox, transfuse based on symptoms only and drain ascities for comfort. . # ascities: the patient has significant ascites and has undergone multiple therapeutic paracentesis to relieve dyspnea and abdominal discomfort. ir placed guided port on . abdominal port is currently draining frank blood (see above), but does provide significant comfort. patient was briefly started on antibiotics (vanc, ceftrioxone) for possible intrapertineal infection based on pmn 249 (), however culture returned negative and antibiotics were discontinued. - drain prn for comfort . # history of dvt/pe: lovenox discontinued in setting of intraperitoneal hemorrhage. # metastatic ovarian cancer: patient discharged home with hospice. - morphine prn - paracentesis via port for comfort - transfusions based on symptoms # fen: encourage po intake # code: dnr/dni medications on admission: 1. lovenox 100mg sq daily (of note did not take am of sunday ) 2. senna 8.6mg daily 3. reglan 5mg po q6hrs prn nausea 4. clonazepam 0.5mg prn anxiety 5. proair hfa 90mcg 1-2puffs q6-8 hrs prn cough 6. dexamethasone 8mg the day before, of and day after chemo 7. famotidine 40mg prn 8. vitamin b-12 9. colace 100mg 10. desipramine 50mg daily 11. folic acid 1mg daily 12. zofran 8mg tid prn nausea 13. alimta q3 weeks, last dose . discharge medications: 1. needles 4p/week 19 gauge, 1 inch for abdominal port access 2. port a cath access kits please provide 3 kits/week 3. saline and heparin flush use prn with abdominal port 4. 3 way stop cock please provide 3 per week 5. 30 cc syringe - lock please provide 3 per week 6. etoh wipes, dressing materials, and needle bucket please provide enough for one month supply indication: abdominal port 7. nephrostomy drainage bag please provide 6 bags per month 8. morphine concentrate 20 mg/ml solution sig: 2-20 mg po q1hr as needed for pain. disp:*30 ml* refills:*0* 9. simethicone 80 mg tablet, chewable sig: one (1) tablet, chewable po qid (4 times a day) as needed for nausea. disp:*30 tablet, chewable(s)* refills:*0* 10. acetaminophen 325 mg tablet sig: one (1) tablet po q6h (every 6 hours) as needed for pain. disp:*30 tablet(s)* refills:*0* 11. senna 8.6 mg tablet sig: one (1) tablet po bid (2 times a day) as needed. disp:*30 tablet(s)* refills:*0* 12. famotidine 20 mg tablet sig: one (1) tablet po q12h (every 12 hours). disp:*60 tablet(s)* refills:*2* 13. cyanocobalamin 100 mcg tablet sig: 0.5 tablet po daily (daily). disp:*30 tablet(s)* refills:*2* 14. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day). disp:*60 capsule(s)* refills:*2* 15. folic acid 1 mg tablet sig: one (1) tablet po daily (daily). disp:*30 tablet(s)* refills:*2* 16. lorazepam 1 mg tablet sig: one (1) tablet po every four (4) hours as needed for anxiety. disp:*30 tablet(s)* refills:*0* 17. zofran 4 mg tablet sig: one (1) tablet po every eight (8) hours as needed for nausea. disp:*30 tablet(s)* refills:*0* 18. desipramine 50 mg tablet sig: one (1) tablet po at bedtime. 19. bisacodyl 10 mg suppository sig: one (1) rectal once a day as needed for constipation. disp:*30 suppository* refills:*0* discharge disposition: home with service facility: hospice of the good discharge diagnosis: ovarian cancer refractory ascites intraperitoneal hemorrhage discharge condition: good, pain well controlled. discharge instructions: you were admitted for low blood counts. you stabilized with blood transfusions. your lovenox was discontinued. an abdominal port was placed to allow frequent paracentesis. . attend all your follow-up appointments. you will have an appointment with dr. and on friday (not tuesday). . follow your medication list, we have changed some of your medications. . call your doctor if you experience dizziness, chest pain, fever, chills, nausea, vomiting, pain or any other concerning symptoms. followup instructions: you will have an appointment with dr. and dr. on friday febuary 20th. they will call you with the time. your appointment on tuesday has been cancelled. procedure: creation of cutaneoperitoneal fistula diagnoses: unspecified essential hypertension hyposmolality and/or hyponatremia anxiety state, unspecified antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use personal history of venous thrombosis and embolism drug induced neutropenia hemoperitoneum (nontraumatic) volume depletion, unspecified secondary malignant neoplasm of retroperitoneum and peritoneum personal history of malignant neoplasm of ovary other specified aplastic anemias malignant ascites 

Answer: The patient is high likely exposed to